Using B cells to protect the brain after traumatic injury
Neuroprotective B Cell Immunotherapy for Contusion Traumatic Brain Injury
This study is looking at how special immune cells called B lymphocytes can help protect the brain and improve healing after a traumatic brain injury, and it’s for people who want to learn about new treatments for TBI.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11042205 on NIH RePORTER |
What this research studies
This research investigates the role of B lymphocytes, a type of immune cell, in protecting the brain following a traumatic brain injury (TBI). The approach involves administering B cells directly to the brain at the time of injury to see if they can reduce damage and improve recovery. The study will explore how these B cells work to promote healing and prevent further degeneration in the brain. By understanding the mechanisms behind their protective effects, the research aims to develop a new therapy for patients suffering from TBI.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recently experienced a contusion traumatic brain injury.
Not a fit: Patients with chronic or long-standing brain injuries may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a novel treatment that significantly improves recovery outcomes for patients with traumatic brain injuries.
How similar studies have performed: Previous studies have shown promising results using B cells in other injury models, suggesting potential for success in this novel application.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Sirbulescu, Ruxandra F — Massachusetts General Hospital
- Study coordinator: Sirbulescu, Ruxandra F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.